EVANGELISTA, LAURA
 Distribuzione geografica
Continente #
AS - Asia 7.205
NA - Nord America 5.866
SA - Sud America 1.412
EU - Europa 1.010
AF - Africa 147
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.664
Nazione #
US - Stati Uniti d'America 5.665
SG - Singapore 4.964
BR - Brasile 1.170
CN - Cina 936
VN - Vietnam 637
DE - Germania 343
IT - Italia 227
HK - Hong Kong 141
IN - India 108
AR - Argentina 86
CA - Canada 83
BD - Bangladesh 78
GB - Regno Unito 76
MX - Messico 66
RU - Federazione Russa 50
EC - Ecuador 47
IQ - Iraq 46
ZA - Sudafrica 41
PL - Polonia 38
TR - Turchia 37
FR - Francia 35
NL - Olanda 32
CO - Colombia 27
ES - Italia 26
ID - Indonesia 26
VE - Venezuela 26
MA - Marocco 25
UA - Ucraina 24
SA - Arabia Saudita 23
AT - Austria 21
PH - Filippine 20
IE - Irlanda 19
AE - Emirati Arabi Uniti 18
JP - Giappone 18
PK - Pakistan 18
SE - Svezia 18
CL - Cile 17
FI - Finlandia 17
KE - Kenya 17
CZ - Repubblica Ceca 16
AU - Australia 13
AZ - Azerbaigian 13
UZ - Uzbekistan 13
IL - Israele 12
TN - Tunisia 12
AL - Albania 11
MY - Malesia 11
NG - Nigeria 11
PE - Perù 11
PY - Paraguay 11
EG - Egitto 10
LT - Lituania 10
NP - Nepal 10
BO - Bolivia 9
DZ - Algeria 9
JM - Giamaica 8
JO - Giordania 8
OM - Oman 8
KG - Kirghizistan 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
HN - Honduras 6
KW - Kuwait 6
LV - Lettonia 6
TW - Taiwan 6
UY - Uruguay 6
CR - Costa Rica 5
GR - Grecia 5
IR - Iran 5
KZ - Kazakistan 5
NI - Nicaragua 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
DK - Danimarca 4
ET - Etiopia 4
GA - Gabon 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BW - Botswana 3
BY - Bielorussia 3
GE - Georgia 3
KH - Cambogia 3
LB - Libano 3
NO - Norvegia 3
NR - Nauru 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
DM - Dominica 2
GY - Guiana 2
HR - Croazia 2
LK - Sri Lanka 2
Totale 15.634
Città #
Singapore 2.084
San Jose 1.288
Ashburn 1.118
Dallas 877
The Dalles 817
Shanghai 409
Falkenstein 224
Ho Chi Minh City 210
Beijing 195
Hanoi 142
Hong Kong 130
São Paulo 111
Los Angeles 108
Santa Clara 80
New York 71
Seattle 68
Milan 47
Boardman 42
Council Bluffs 40
Da Nang 36
Brooklyn 32
Warsaw 31
Assago 30
Montreal 30
Chandler 29
Chennai 29
Haiphong 29
Orem 29
Buffalo 27
Munich 27
Rio de Janeiro 27
Curitiba 26
Rome 25
Wilmington 24
Brasília 23
Belo Horizonte 21
Boston 21
Chicago 21
Toronto 21
Dhaka 20
Guayaquil 20
Dublin 18
Johannesburg 18
Mexico City 18
Baghdad 17
Goiânia 17
Stockholm 17
Atlanta 16
Campinas 16
Helsinki 16
Buenos Aires 15
Phoenix 15
Quito 15
Tokyo 15
Charlotte 14
San Mateo 14
Amsterdam 13
Ann Arbor 13
London 13
Nairobi 13
Baku 12
Biên Hòa 12
Frankfurt am Main 12
Porto Alegre 12
Salvador 12
San Francisco 12
Bắc Ninh 11
Denver 11
Guarulhos 11
Ribeirão Preto 11
Brno 10
Cape Town 10
Düsseldorf 10
Fortaleza 10
Hangzhou 10
Istanbul 10
New Delhi 10
Reston 10
Santo André 10
Tashkent 10
Vienna 10
Ankara 9
Bắc Giang 9
Dubai 9
Houston 9
Jeddah 9
Riyadh 9
Caxias do Sul 8
Hải Dương 8
Lima 8
Manila 8
Montes Claros 8
Nuremberg 8
Santiago 8
Sumaré 8
Thái Nguyên 8
Agadir 7
Amman 7
Bishkek 7
Blumenau 7
Totale 9.312
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 626
PET-CT radiomics for immunotherapy response 163
18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients 117
BNCT treatment: 18F-FBPA PET-CT 96
A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT 94
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 87
Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice 82
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 82
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 80
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy 78
18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case 78
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives 77
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 76
An incidental pancreatic finding at 18F-choline PET/CT: Chronic mass-forming pancreatitis 75
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 73
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET 70
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 63
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 62
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 61
Advancing Prostate Cancer Care: Prostate-specific Membrane Antigen–based Radioligand Therapy at the Forefront 59
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 59
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 58
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 58
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 57
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis 57
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 56
Relazione tra ischemia miocardica inducibile e livelli plasmatici di proteina C reattiva in pazienti con sospetta cardiopatia ischemica 56
18F-Choline PET/CT: An Alternative Tracer for Hodgkin Lymphoma? 55
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block 55
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 55
Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis? 55
Diagnosi e stadiazione del cancro della mammella Il Medico Nucleare: stato dell’arte e risposta ai punti controversi 54
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 54
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 53
18F-choline PET/CT in prostate cancer for the staging, the restaging and planning radiotherapy treatment 53
L’imaging funzionale nelle disautonomie 52
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 52
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 52
18F-Choline PET/CT and prostatic gland/fossae recurrence: what can help to identify the local recurrence of disease? 52
18F-Choline: Prostate Cancer18F-choline PET/CT: an increasing role in cancer evaluation 52
18F-DOPA PET/CT in different neuroendocrine settings: staging, restaging and increase in tumor markers 52
[18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers 51
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 51
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 51
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 50
18F-FDG PET/CT in gynecologic malignancies: single Institution experience 50
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 49
Clinical Application of PET/MRI 49
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today’s impact, tomorrow’s potential 49
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer 49
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients 48
18F-FDG PET/MRI in adult sarcomas 48
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 48
Copper, PeT/cT and prostate cancer: A systematic review of the literature 47
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review 47
18F-Fluoroestradiol positron emission tomography in breast cancer patients: systematic review of the literature & meta-analysis 47
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 47
Comparison of prognostic value of baseline and nitrate Single-photon Emission computed tomography imaging in patients with ischaemic left ventricular dysfunction 47
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer 47
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 46
Ruolo della Tomografia ad emissione di fotone singolo nella definizione della probabilità di cardiopatia ischemica nei pazienti diabetici: risultati di un trial multi prospettico, multicentrico 45
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 45
Usefullness of stress cardiac single photon emission computesd tomography iomaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 45
Incidental Detection of Sarcomatoid Lung Cancer by [18F] Choline Positron Emission Tomography/Computed Tomography 45
PET-guided prognosis: a promising role of metabolic imaging in esophageal cancer. 45
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review 45
An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor 45
Indeterminate pulmonary nodules on CT images in breast cancer patient: The additional value of 18F-FDG PET/CT 45
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 45
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 44
18F-FDG PET/CT in ovarian cancer 44
ENDOCRINE ORGANS INVOLVEMENT IN BREAST CANCER: WHEN THE TEAMWORK MAKES THE DIFFERENCE 44
The performance of FDG PET/CT in single pulmonary nodules (SPNs): preliminary analysis from The Italian Tailored Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) multicentre trial 43
Il radiologo e il medico nucleare: nodulo/i polmonare/i 43
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 43
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review 43
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography 43
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma 42
Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature 42
EARLY AND LATE IMAGES OF 18F-CHOLINE (FCH) PET/CT FOR THE DETECTION OF PROSTATIC FOSSAE RECURRENCES IN PROSTATE CANCER WITH A BIOCHEMICAL FAILURE (PSA< 2 NG/ML) 42
A false-positive finding in 18F-FDG PET/CT images in patients with right Malignant Pleural Mesothelioma (MPM) after extrapleural pneumonectomy 42
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 42
Role of FDG-PET/CT in the staging of colonrectal cancer 42
An incidental finding behind adrenal incidentaloma 42
Risk stratification and prognostic assessment by myocardial perfusion-gated SPECT in patients with left bundle-branch block and low-intermediate cardiac risk 42
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases 42
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update 42
Tumour marker guided Positron Emission Tomography in Breast Cancer patients: A recipe for a perfect wedding. A systematic literature review & meta-analysis 42
What are the best ways to reduce the false-positive rate of 18F-FDG PET/CT in patients with breast cancer? 41
Effects of the High Definition technology on Standardized Uptake Values (SUVs) obtained by Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) 41
Additional value of pet radiomic features for the initial staging of prostate cancer: A systematic review from the literature 41
Ruolo della PET/scintigrafia ossea? 41
PET/CT And The Response To Immunotherapy In Lung Cancer 41
Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature 41
Role of SPECT imaging in the definition of cardiac risk in daibetic patients without history of coronary artery disease: results of a prospective, multi-center trials 41
Molecular imaging of PARP in cancer: state-of-the-art 41
Accuracy of 18F-FDG PET/CT versus bone marrow biopsy in assessing bone marrow involvement in paediatric Hodgkin's Lymphoma. Accuracy in a multicenter series of 156 patients 41
Impact of Inducible Ischemia by Stress SPECT in Cardiac Risk Assessment in Diabetic Patients: Results of a Prospective, Multicenter Trial 41
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases 41
From Bottleneck to Enabler: A New Approach to Regulating Data-Driven Medical Research 41
Totale 5.973
Categoria #
all - tutte 92.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202229 1 0 1 8 1 2 1 1 4 2 6 2
2022/202375 12 5 8 12 3 5 0 3 14 5 8 0
2023/20241.081 2 5 9 4 1 10 3 4 357 59 272 355
2024/20254.216 114 153 19 74 49 492 214 201 839 1.094 461 506
2025/202610.618 1.564 666 858 798 407 597 3.329 659 460 633 280 367
Totale 16.074